These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35865943)

  • 21. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
    Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
    Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of
    Sung C; Tan L; Limenta M; Ganesan G; Toh D; Chan CL
    Front Pharmacol; 2020; 11():527. PubMed ID: 32457602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
    Neuman MG; Cohen L; Nanau RM; Hwang PA
    Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-B
    Min FL; Mao BJ; Zheng ZZ; He N; Fan CX; Cai RY; Wang J; Ou YM; Qin B; Liao WP; Yi YH; Li Z; Shi YW
    Front Neurol; 2019; 10():614. PubMed ID: 31263447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine versus Carbamazepine for the Treatment of Post-Stroke Epilepsy: A Systematic Review and Meta-Analysis.
    Zhang YJ; Lu XM; Li PW; Guo CA; Wan DJ
    Turk Neurosurg; 2022; 32(2):176-184. PubMed ID: 34936076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese.
    Nguyen DV; Chu HC; Nguyen DV; Phan MH; Craig T; Baumgart K; van Nunen S
    Asia Pac Allergy; 2015 Apr; 5(2):68-77. PubMed ID: 25938071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
    Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.
    Johannessen Landmark C; Svendsen T; Dinarevic J; Kufaas RF; Reimers A; Brodtkorb E; Baftiu A; Burns ML; Johannessen SI
    Ther Drug Monit; 2016 Aug; 38(4):499-505. PubMed ID: 27414974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
    Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia.
    Xue H; Xiang W; Yu Y; Liu G; Chong Y; Zhou J
    Drug Des Devel Ther; 2018; 12():837-843. PubMed ID: 29695895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study.
    Shirzadi M; Thorstensen K; Helde G; Moen T; Brodtkorb E
    Epilepsy Res; 2015 Dec; 118():5-9. PubMed ID: 26555631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Factors Impacting the Efficacy of Single or Combination Therapies of Valproic Acid, Carbamazepine, and Oxcarbazepine: A Longitudinal Observation Study.
    Peng Q; Ma M; Gu X; Hu Y; Zhou B
    Front Pharmacol; 2021; 12():641512. PubMed ID: 34017250
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
    Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
    Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.
    Ihtisham K; Ramanujam B; Srivastava S; Mehra NK; Kaur G; Khanna N; Jain S; Kumar S; Kaul B; Samudrala R; Tripathi M
    Seizure; 2019 Mar; 66():99-103. PubMed ID: 30826555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
    Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
    Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical recommendations for oxcarbazepine.
    Smith PE;
    Seizure; 2001 Mar; 10(2):87-91. PubMed ID: 11421225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.